Since the COVID-19 pandemic, several research studies have proposed Deep Learning (DL)-based automated COVID-19 detection, reporting high cross-validation accuracy when classifying COVID-19 patients from normal or other common Pneumonia. Although the reported outcomes are very high in most cases, these results were obtained without an independent test set from a separate data source(s). DL models are likely to overfit training data distribution when independent test sets are not utilized or are prone to learn dataset-specific artifacts rather than the actual disease characteristics and underlying pathology. This study aims to assess the promise of such DL methods and datasets by investigating the key challenges and issues by examining the compositions of the available public image datasets and designing different experimental setups. A convolutional neural network-based network, called CVR-Net (COVID-19 Recognition Network), has been proposed for conducting comprehensive experiments to validate our hypothesis. The presented end-to-end CVR-Net is a multi-scale-multi-encoder ensemble model that aggregates the outputs from two different encoders and their different scales to convey the final prediction probability. Three different classification tasks, such as 2-, 3-, 4-classes, are designed where the train-test datasets are from the single, multiple, and independent sources. The obtained binary classification accuracy is 99.8% for a single train-test data source, where the accuracies fall to 98.4% and 88.7% when multiple and independent train-test data sources are utilized. Similar outcomes are noticed in multi-class categorization tasks for single, multiple, and independent data sources, highlighting the challenges in developing DL models with the existing public datasets without an independent test set from a separate dataset. Such a result concludes a requirement for a better-designed dataset for developing DL tools applicable in actual clinical settings. The dataset should have an independent test set; for a single machine or hospital source, have a more balanced set of images for all the prediction classes; and have a balanced dataset from several hospitals and demography. Our source codes and model are publicly available for the research community for further improvements.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005223 | PMC |
http://dx.doi.org/10.1016/j.imu.2022.100945 | DOI Listing |
J Med Internet Res
January 2025
Vibrent Health, Inc, Fairfax, VA, United States.
Background: Longitudinal cohort studies have traditionally relied on clinic-based recruitment models, which limit cohort diversity and the generalizability of research outcomes. Digital research platforms can be used to increase participant access, improve study engagement, streamline data collection, and increase data quality; however, the efficacy and sustainability of digitally enabled studies rely heavily on the design, implementation, and management of the digital platform being used.
Objective: We sought to design and build a secure, privacy-preserving, validated, participant-centric digital health research platform (DHRP) to recruit and enroll participants, collect multimodal data, and engage participants from diverse backgrounds in the National Institutes of Health's (NIH) All of Us Research Program (AOU).
Rev Gaucha Enferm
January 2025
RISE - Rede de Investigação em Saúde. Porto, Portugal.
Objective: To map the literature on the use of exergames in the rehabilitation of school-age children with brain tumors, in any context.
Method: Scoping review protocol developed using the recommendations of the Joanna Briggs Institute. The search will include aggregators, databases, indexes, repositories, and research browsers, without limitation as to the year of publication.
J Appl Physiol (1985)
January 2025
Department of Human Physiology, Gonzaga University, Spokane, Washington, United States.
We tested the hypothesis that power at maximal metabolic steady state is similar between fitness matched men and women. Eighteen participants (9 men, 9 women) performed a cycling graded exercise test for maximal oxygen consumption (V̇O). Men and women were matched for V̇O normalized to fat free mass (FFM), which was 50.
View Article and Find Full Text PDFPLoS One
January 2025
Department of Clinical Physiology, Karolinska University Hospital, Stockholm, Sweden.
Background: The causes of reduced aerobic exercise capacity (ExCap) in chronic kidney disease (CKD) are multifactorial, possibly involving the accumulation of tryptophan (TRP) metabolites such as kynurenine (KYN) and kynurenic acid (KYNA), known as kynurenines. Their relationship to ExCap has yet to be studied in CKD. We hypothesised that aerobic ExCap would be negatively associated with plasma levels of TRP, KYN and KYNA in CKD.
View Article and Find Full Text PDFEur Heart J Cardiovasc Imaging
January 2025
Department of Clinical Science and Education, Division of Cardiology, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden.
Aims: The REDUCE-AMI trial showed that beta-blockers in patients with preserved left ventricular ejection fraction (LVEF) after acute myocardial infarction (AMI) had no effect on mortality or cardiovascular outcomes. The aim of this substudy was to evaluate whether global longitudinal strain (GLS) is a better prognostic marker than LVEF, and if beta-blockers have a beneficial effect in patients with decreased GLS.
Methods And Results: REDUCE-AMI was a registry-based randomized clinical trial.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!